CSL valuation pumping via blood rush despite ozempic effect
MELBOURNE: A casual visitor to the ASX from another universe watching CSL’s valuation ... read more
Neuren Pharma tumbles 14pc on short-seller report
NEW YORK: Neuren Pharmaceuticals has rebuked a short seller report targeting its US-listed ... read more
GenesisCare emerges from bankruptcy and re-enters oncology
BRISBANE: Health officials will launch an independent review into the financial viability of ... read more
